DR. SOLVEIG G ERICSON, M. D.
Osteopathic Medicine at Stadium Dr, Morgantown, WV
License number
West Virginia 18075
Category
Osteopathic Medicine
Type
Hematology & Oncology
Address
Address
1 Stadium Dr, Morgantown, WV 26506
Phone
(304) 598-4800
(304) 293-6963 (Fax)
(304) 293-7401
(304) 293-6963 (Fax)
(304) 293-7401
Personal information
See more information about SOLVEIG G ERICSON at radaris.comName
Address
Phone
829 Briarwood St, Morgantown, WV 26505
Professional information
Dr. Solveig G Ericson, Morgantown WV - MD (Doctor of Medicine)
Specialties:
Hematology, Medical Oncology, Oncology
Address:
1 Stadium Dr, Morgantown 26506
(304) 598-4800 (Phone), (304) 293-6963 (Fax)
(304) 598-4800 (Phone), (304) 293-6963 (Fax)
Certifications:
Hematology, 1997, Internal Medicine, 1990, Medical Oncology, 1991
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
1 Stadium Dr, Morgantown 26506
West Virginia University Hospitals
1 Medical Center Dr, Morgantown 26506
West Virginia University Hospitals
1 Medical Center Dr, Morgantown 26506
Education:
Medical School
Boston University School of Medicine
Graduated: 1985
St Elizabeths Hosp
Brown U Affil Hosps
Dartmouth-Hitchcock Med Ctr
Boston University School of Medicine
Graduated: 1985
St Elizabeths Hosp
Brown U Affil Hosps
Dartmouth-Hitchcock Med Ctr
Solveig Ericson, Morgantown WV
Specialties:
Internal Medicine, Hematology & Oncology, Hematology, Medical Oncology
Work:
Mary Babb Randolph Cancer Ctr
1 Stadium Dr, Morgantown, WV 26506
1 Stadium Dr, Morgantown, WV 26506
Education:
Boston University(1985)
Compositions And Methods For The Detection Of Human T Cell Receptor Variable Family Gene Expression
US Patent:
2004001, Jan 22, 2004
Filed:
Jul 2, 2003
Appl. No.:
10/612121
Inventors:
Jamie Brewer - Clarksburg WV, US
Solveig Ericson - Morgantown WV, US
Solveig Ericson - Morgantown WV, US
International Classification:
C12Q001/68, G06F019/00, G01N033/48, G01N033/50, C12P019/34
US Classification:
435/006000, 435/091200, 702/020000
Abstract:
Compositions and methods for the assessment of T cell receptor variable subunits. The present invention provides nucleotide sequences for the evaluation of the expression of TCRV families. These nucleotides sequences were obtained through a bioinformatic investigation of the nucleotide sequences for TCRV and TCRV families. The nucleotide sequences of the present invention uniquely recognize each and every subfamily and allelic member of a particular TCRV family, while at the same time not recognizing the members of any other TCRV family. This unique expression recognition profile of the nucleotide sequences of the present invention provides great utility for the assessment of TCR families in a clinical setting, such as through polymerase chain reactions, gene chip technology, and direct electrophoretic measurement of DNA or RNA.